» Articles » PMID: 14985162

Yield of Human Adipose-derived Adult Stem Cells from Liposuction Aspirates

Overview
Journal Cytotherapy
Publisher Elsevier
Date 2004 Feb 27
PMID 14985162
Citations 243
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Primary cultures of isolated human adipose-derived adult stem (ADAS) cells are multipotent and differentiate in vitro along the adipocyte, chondrocyte, neuronal, osteoblast, and skeletal muscle pathways.

Methods: We examined the ADAS cell yield per unit volume of liposuction tissue, and their surface protein phenotype by flow cytometry. Adipogenesis was assessed by Oil Red O staining and ELISA analysis of leptin secretion.

Results: The donor population was 87.5% female (n=18) with a mean age (+/-SD) of 44+/-10 years and body mass index (BMI) of 24.9+/-2.7. The mean cell yield was 404 000+/-206 000 cells per milliliter of lipoaspirate (n=18). Linear regression analysis of the cells derived from the female donors demonstrated a significant negative correlation between the number of cells obtained per milliliter of lipoaspirate with the BMI but not the age of the donor. The undifferentiated ADAS cells were homogeneously positive for the cell-surface markers CD10, CD13, CD29, CD44, CD49e, CD59, CD90, and HLA-ABC, and homogeneously negative for the cell surface markers CD11b, CD45, and HLA-DR. The absence of the panhematopoietic marker, CD45, indicates that the ADAS cells do not derive from circulating BM hematopoietic stem cells. Adipocyte differentiation led to a 5.1-fold increase in Oil Red O staining, and a 196-fold increase in leptin secretion levels. Culture of the cells in the presence of antibiotic and fungizone did not alter the undifferentiated ADAS cell immunophenotype based on flow cytometry, or their adipocyte differentiation based on leptin secretion.

Discussion: The ability to isolate a consistently homogeneous population of undifferentiated adult stem cells from adipose tissue of multiple donors supports their potential utility in future tissue-engineering applications.

Citing Articles

Can cell-cultured meat from stem cells pave the way for sustainable alternative protein?.

Nunes O, Buranello T, Farias F, Rosero J, Recchia K, Bressan F Curr Res Food Sci. 2025; 10:100979.

PMID: 40040753 PMC: 11878651. DOI: 10.1016/j.crfs.2025.100979.


Arthroscopic debridement followed by intra-articular injection of micro-fragmented adipose tissue in patients affected by knee osteoarthritis: Clinical results up to 48 months from a prospective clinical study.

Bruno A, Anzillotti G, De Donato M, Basso M, Tamini J, Dupplicato P J Exp Orthop. 2025; 12(1):e70144.

PMID: 39830171 PMC: 11739897. DOI: 10.1002/jeo2.70144.


"SAVE"-Shock-Assisted Viable Extraction: A Minimally Manipulative Method of Processing Regenerative Cells for Clinical Use.

Del Vecchio D, Vranis N, Alevrogianni K, Theodorou S Aesthet Surg J Open Forum. 2025; 7:ojae112.

PMID: 39790718 PMC: 11712265. DOI: 10.1093/asjof/ojae112.


Optimization and Implication of Adipose-Derived Stem Cells in Craniofacial Bone Regeneration and Repair.

Gu C, Tang Q, Li L, Chen Y Bioengineering (Basel). 2024; 11(11).

PMID: 39593759 PMC: 11592193. DOI: 10.3390/bioengineering11111100.


Donor Sites and Harvesting Techniques Affect miRNA Cargos of Extracellular Vesicles Released by Human Adipose-Derived Mesenchymal Stromal Cells.

Visconte C, Taiana M, Colombini A, De Luca P, Ragni E, de Girolamo L Int J Mol Sci. 2024; 25(12).

PMID: 38928156 PMC: 11203784. DOI: 10.3390/ijms25126450.